fluoxetine has been researched along with 1-methyl-4-phenylpyridinium in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Brooks, WJ; Jarvis, MF; Wagner, GC | 1 |
Keating, E; Martel, F | 1 |
Han, YS; Lee, CS | 1 |
Bok, E; Chung, ES; Chung, YC; Jin, BK; Jin, M; Kim, SR; Kim, YS; Ko, HW; Park, ES; Park, JY; Park, KW; Won, SY; Yoon, SH | 1 |
Al-Monajjed, R; Ciarimboli, G; Dobrivojevic, M; Edemir, B; Harrach, S; Holle, SK; Klassen, P; Massmann, V; Pavenstädt, H; Schlatter, E; Sindic, A | 1 |
6 other study(ies) available for fluoxetine and 1-methyl-4-phenylpyridinium
Article | Year |
---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Astrocytes as a primary locus for the conversion MPTP into MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Astrocytes; Biotransformation; Corpus Striatum; Dopamine; Fluoxetine; Male; Mice; Monoamine Oxidase; Neurotoxins; Pyridines; Pyridinium Compounds; Reference Values; Serotonin | 1989 |
Uptake of 1-methyl-4-phenylpyridinium (MPP+) by the JAR human placental choriocarcinoma cell line: comparison with 5-hydroxytryptamine.
Topics: 1-Methyl-4-phenylpyridinium; Carrier Proteins; Cell Line, Tumor; Choriocarcinoma; Desipramine; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Placenta; Quinolinium Compounds; Serotonin; Serotonin Plasma Membrane Transport Proteins; Uterine Neoplasms | 2003 |
Antidepressants reveal differential effect against 1-methyl-4-phenylpyridinium toxicity in differentiated PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Amitriptyline; Animals; Antidepressive Agents; Apoptosis; Cell Culture Techniques; Cell Differentiation; Cell Nucleus; Cell Survival; DNA Fragmentation; Fluoxetine; Membrane Potential, Mitochondrial; Mitochondrial Membranes; Oxidative Stress; PC12 Cells; Permeability; Rats; Tranylcypromine | 2009 |
Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Cell Count; Coculture Techniques; Corpus Striatum; Cytokines; Dopamine; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Microglia; MPTP Poisoning; NADPH Oxidases; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress; Recovery of Function; Rotarod Performance Test; Substantia Nigra | 2011 |
The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cells, Cultured; Diazepam; Fluoxetine; HEK293 Cells; Histamine; Humans; Ion Transport; Ketamine; Kidney Tubules, Proximal; Male; Mice; Octamer Transcription Factor-3; Organic Cation Transport Proteins; Psychotropic Drugs; Quaternary Ammonium Compounds; Serotonin; Species Specificity | 2014 |